• Something wrong with this record ?

Live Birth Following Uterine Transplantation From a Nulliparous Deceased Donor

J. Fronek, L. Janousek, J. Kristek, J. Chlupac, M. Pluta, R. Novotny, J. Maluskova, M. Olausson

. 2021 ; 105 (5) : 1077-1081. [pub] 20210501

Language English Country United States

Document type Case Reports, Research Support, Non-U.S. Gov't

BACKGROUND: Nulliparous uterine grafts have never been used in uterus transplantation (UTx), possibly due to presumed infertility. Our objective was to verify the feasibility of nulliparous uterine graft transplantation. METHODS: The Czech Uterus Transplant Trial (registered under ClinicalTrials.gov, identifier NCT03277430) is a 2-arm trial comparing the efficacy of deceased donor (DD) versus live-donor uterus transplant (10 patients in both arms). A 25-year-old patient suffering from inborn absolute uterine factor infertility underwent a DD uterus transplant. The donor was a 20-year-old nulliparous brain-dead donor. RESULTS: The transplant procedure was uneventful. The posttransplant period was complicated by (1) recurrent episodes of acute cellular rejection, (2) neutropenia necessitating the administration of granulocyte colony-stimulating factor, (3) vaginal anastomotic stenosis treated with the insertion of a self-expanding stent, (4) the concurrence of Clostridium difficile colitis and acute appendicitis, and (5) temporary renal function impairment of a combined cause. Two years after the UTx, after the fourth embryo transfer, the patient became pregnant. Apart from gestational diabetes mellitus, the pregnancy was uneventful. Due to preterm contractions, delivery was achieved via caesarean section at gestational age 34 + 6 years. The postoperative course was uneventful for both the mother and the newborn. CONCLUSIONS: Herein, we report the first live birth after a DD UTx in Europe. This report provides a proof of concept that nulliparous uteri may present a suitable source of uterine grafts for UTx. Stenting may serve as a feasible treatment method for vaginal anastomotic stenosis.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21025820
003      
CZ-PrNML
005      
20211026133453.0
007      
ta
008      
211013s2021 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1097/TP.0000000000003346 $2 doi
035    __
$a (PubMed)32541565
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Fronek, Jiri $u Transplant Surgery Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $u Second Faculty of Medicine, Charles University, Prague, Czech Republic $u First Faculty of Medicine, Charles University, Prague, Czech Republic $u Department of Anatomy, Second Faculty of Medicine, Charles University, Prague, Czech Republic
245    10
$a Live Birth Following Uterine Transplantation From a Nulliparous Deceased Donor / $c J. Fronek, L. Janousek, J. Kristek, J. Chlupac, M. Pluta, R. Novotny, J. Maluskova, M. Olausson
520    9_
$a BACKGROUND: Nulliparous uterine grafts have never been used in uterus transplantation (UTx), possibly due to presumed infertility. Our objective was to verify the feasibility of nulliparous uterine graft transplantation. METHODS: The Czech Uterus Transplant Trial (registered under ClinicalTrials.gov, identifier NCT03277430) is a 2-arm trial comparing the efficacy of deceased donor (DD) versus live-donor uterus transplant (10 patients in both arms). A 25-year-old patient suffering from inborn absolute uterine factor infertility underwent a DD uterus transplant. The donor was a 20-year-old nulliparous brain-dead donor. RESULTS: The transplant procedure was uneventful. The posttransplant period was complicated by (1) recurrent episodes of acute cellular rejection, (2) neutropenia necessitating the administration of granulocyte colony-stimulating factor, (3) vaginal anastomotic stenosis treated with the insertion of a self-expanding stent, (4) the concurrence of Clostridium difficile colitis and acute appendicitis, and (5) temporary renal function impairment of a combined cause. Two years after the UTx, after the fourth embryo transfer, the patient became pregnant. Apart from gestational diabetes mellitus, the pregnancy was uneventful. Due to preterm contractions, delivery was achieved via caesarean section at gestational age 34 + 6 years. The postoperative course was uneventful for both the mother and the newborn. CONCLUSIONS: Herein, we report the first live birth after a DD UTx in Europe. This report provides a proof of concept that nulliparous uteri may present a suitable source of uterine grafts for UTx. Stenting may serve as a feasible treatment method for vaginal anastomotic stenosis.
650    _2
$a poruchy sexuálního vývoje s karyotypem 46, XX $x komplikace $7 D058489
650    _2
$a dospělí $7 D000328
650    _2
$a vrozené vady $7 D000013
650    _2
$a výběr dárců $7 D046148
650    _2
$a ženské pohlaví $7 D005260
650    12
$a fertilita $7 D005298
650    _2
$a lidé $7 D006801
650    _2
$a ženská infertilita $x diagnóza $x etiologie $x patofyziologie $x chirurgie $7 D007247
650    _2
$a narození živého dítěte $7 D050498
650    _2
$a ductus Mülleri $x abnormality $7 D009095
650    12
$a parita $7 D010298
650    _2
$a pooperační komplikace $x etiologie $x terapie $7 D011183
650    _2
$a těhotenství $7 D011247
650    _2
$a asistovaná reprodukce $7 D027724
650    _2
$a stenty $7 D015607
650    _2
$a doba do početí $7 D061685
650    12
$a dárci tkání $7 D014019
650    _2
$a výsledek terapie $7 D016896
650    _2
$a uterus $x transplantace $7 D014599
650    _2
$a mladý dospělý $7 D055815
655    _2
$a kazuistiky $7 D002363
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Janousek, Libor $u Transplant Surgery Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $u First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Kristek, Jakub $u Transplant Surgery Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $u Department of Anatomy, Second Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Chlupac, Jaroslav $u Transplant Surgery Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $u Second Faculty of Medicine, Charles University, Prague, Czech Republic $u Department of Anatomy, Second Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Pluta, Marek $u Department of Obstetrics and Gynaecology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
700    1_
$a Novotny, Robert $u Transplant Surgery Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Maluskova, Jana $u Department of Clinical and Transplant Pathology, Institute of Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Olausson, Michael $u Department of Transplantation Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden
773    0_
$w MED00010695 $t Transplantation $x 1534-6080 $g Roč. 105, č. 5 (2021), s. 1077-1081
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32541565 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20211026133500 $b ABA008
999    __
$a ok $b bmc $g 1714739 $s 1146327
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 105 $c 5 $d 1077-1081 $e 20210501 $i 1534-6080 $m Transplantation $n Transplantation $x MED00010695
LZP    __
$a Pubmed-20211013

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...